• Capturing Pre-Commercial-$tage Value

    Welcome to Life Science Deal Flow. Our aim here is to hold my mouse to the fire by documenting the winners (and losers) of my life science trades and strategies. The focus is on a unique opportunities presented by pre-commercial stage life science entities. Don't forget to visit and subscribe to my other site, a FREE Venture Capital and competitive intelligence dBase, OnBioVC.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

Come meet and network with Life Science Deal Flow and OnBioVC at our Office Hours on 08 July in Cambridge, MA. For details on oHours (time/place) and to sign-up for a time slot visit HERE. We look forward to connecting with you! [Trouble with the oHours sign-up link? Then paste this url in your browser [...]

Our Life Science Deal Flow PDUFA Trade Strategy is not applicable to just any approaching date. There are several dates this month; Celgene’s (Nasdaq: CELG) istodax®, for relapsed and refractory peripheral T-cell lymphoma, Acura Pharmaceutical’s (Nasdaq: ACUR) acurox®, an abuse-resistant pain med, and Fibrorcell Science’s (Nasdaq: FCSC) iaviv®, for the treatment of moderate to serve [...]

OnBioVC and Life Science Deal Flow are excited to announce our newest premium content site, The Email MBA, a resource to address simple to sophisticated business questions and quandaries; designed for those who are short on time and long on the desire to better understand critical concepts, from venture financings to IP management to term-sheet strategy, and much more. [...]

Apologies…It appears as though the video has been taken down? In the whole wide lab… If you are reading this in email or a RSS feeder be certain to click [HERE] for the most beautiful girl in the lab; courtesy of the endlessly entertaining grad students at UCSF.

Well then look no further than the Colorado Institute for Drug, Device and Diagnostic Development (aka CID4). CID4 has issued a Fall 2010 Statewide “Call for Proposals” from Colorado-based life science inventors, academics and private companies. Founded in 2009, CID4 is a not-for-profit entity whose mission is to drive Colorado bioscience company and job growth [...]

Hot off the press! The 2Q10 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 2Q10 OnBioVC Trend Analysis tracked, in aggregate, 81 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,664.2M. Compared to 1Q10 OnBioVC data, this investment activity represents an increase in the [...]

Good stuff here. The first ~seven minutes are intro, then comes a variety of introductory concepts related to Terms in the Term Sheet. Considering these are tech investors I thought they could do a better job with displaying the spreadsheet, but that is being knit-picky. Grab a cup of yerba mate and enjoy… Click [HERE] [...]

If you have not been paying attention lately, perhaps this will jar something loose…$1BILLION IN CASH GRANTS AVAILABLE FOR EMERGING LIFE SCIENCE COMPANIES aka Section 48D of the IRS code “The Qualifying Therapeutic Discovery Project Credit”. That get your attention? Good. The recently enacted healthcare reform legislation provides up to $1 billion in tax credits [...]

Contribute to the Conversation at the: Job Creation and Entrepreneurship Forum University of Denver, The Chambers Center, the Garden Room Friday, May 14th, 2010 2:30 pm-5:00 pm How do we create the jobs of the 21st century? How do we create the right environment for the next generation of entrepreneurs? Creating the companies and jobs [...]

Hello Friends and Colleagues. Here is an event you are not going to want to miss. Admission is ***FREE*** but seats are limited! Please RSVP at http://GoldLabSymposium.com 2010 GoldLab Symposium – Time: The Crucial Fourth Dimension of Personalized Medicine GoldLab announces the upcoming GoldLab Inaugural Symposium 2010–Time: The Crucial Fourth Dimension of Personalized Medicine scheduled [...]

Hot off the press! The 1Q10 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 1Q10 OnBioVC Trend Analysis tracked, in aggregate, 74 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,260.1M. Compared to 1Q09 OnBioVC data, this investment activity represents a decrease in the [...]

So based upon the recent ruling of Myriad Genetics (NASDAQ: MYGN) invalidation of certain patents covering the BRCA1 and BRCA2 genes, I was planning on levering the news as fodder for an all out April Fools’ post effort, likely to have been something along the lines of ‘10,000 Gene-based Patents Overturned, Biotechnology Industry Implodes’. A [...]

The 2010 Season of BioBeers kicks-off on Tuesday 2 March 6:30pm. This is not your mother’s, uncle’s, brother’s BioBeers. The format has been re-engineered with the hope that you will find attending the Meetups more valuable than ever. But it takes a village to make BioBeers, that is why I urge you to visit http://www.BioBeers.com [...]

« Previous Entries  Next Page »

to top of page...


 
  • The Latest LSDF Activity

    February 2012
    M T W T F S S
    « Oct    
     12345
    6789101112
    13141516171819
    20212223242526
    272829  
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com